UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
 
FORM 8-K
 
CURRENT REPORT
Pursuant to Section 13 or 15(d) of
The Securities Exchange Act of 1934
 
Date of Report (Date of earliest event reported) May 13, 2011
 
ICU Medical, Inc.
(Exact name of registrant as specified in its charter)
 
DELAWARE
 
0-19974
 
33-0022692
(State or other jurisdiction
of incorporation)
 
(Commission File Number)
 
(IRS Employer Identification No.)
 
 
951 Calle Amanecer, San Clemente, California
 
92673
 
 
(Address of principal executive offices)
 
(Zip Code)
 
 
(949) 366-2183
Registrant's telephone number, including area code
 
N/A
(Former name or former address, if changed since last report)
 
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):
 
[ ]
  Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
 
[ ]
  Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
 
[ ]
  Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
 
[ ]
  Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
 
 
 

 
Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.

At the 2011 Annual Meeting of Stockholders (the “Annual Meeting”) of ICU Medical, Inc. (the “Company”), held on May 13, 2011, the Company’s stockholders approved the ICU Medical, Inc. 2011 Stock Incentive Plan (the “2011 Stock Incentive Plan”), which, among other things, provides for the issuance of options and other types of awards covering up to an aggregate of 899,700 shares of the Company’s common stock (i.e., the 650,000 shares approved under the 2011 Stock Incentive Plan plus the 249,700 shares that remain available for grants under the 2003 Stock Option Plan as of May 13, 2011) to employees, directors and consultants of the Company.

The foregoing description of the 2011 Stock Incentive Plan is only a summary and is qualified in its entirety by the full text of the 2011 Stock Incentive Plan, which is filed as Exhibit 10.1 to this Current Report on Form 8-K and incorporated herein by reference.

Item 5.07 Submission of Matters to a Vote of Security Holders.

At the Annual Meeting, the following proposals were voted on by the Company’s stockholders, as set forth below:
 
Proposal 1. Election of Directors.
             
Name of Nominee
 
Votes For
 
Votes Withheld
 
Broker Non-Votes
     John J. Connors
  
11,002,697
 
218,140
 
1,081,694
     Michael T. Kovalchik, III, M.D.
  
10,960,748
 
260,089
 
1,081,694
     Joseph R. Saucedo
 
11,017,874
 
202,963
 
1,081,694

Each of the director nominees was elected to serve as a director until the 2014 annual meeting of stockholders and until their respective successors are elected and qualified.

Proposal 2. Ratification of the appointment of Deloitte & Touche LLP as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2011.
             
Votes For
 
Votes Against
 
Abstain
 
Broker Non-Votes
12,269,881
 
16,679
 
15,971
 
N/A

The appointment of Deloitte & Touche LLP as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2011 was ratified.

Proposal 3. Advisory vote on Executive Compensation.
             
Votes For
 
Votes Against
 
Abstain
 
Broker Non-Votes
9,367,313
 
1,773,239
 
80,285
 
1,081,694

The Company’s executive compensation was approved on a non-binding, advisory basis.
 
Proposal 4. Advisory Vote on the Frequency of the Advisory Vote on Executive Compensation.
                 
One Year
 
Two Years
 
Three Years
 
Abstain
 
Broker Non-Votes
8,696,801
 
47,597
 
2,399,509
 
76,930
 
1,081,694

The option of holding the advisory vote on executive compensation every year was approved on a non-binding, advisory basis by a majority of the votes cast on the proposal.

Proposal 5. Approval of the ICU Medical, Inc. 2011 Stock Incentive Plan.
             
Votes For
 
Votes Against
 
Abstain
 
Broker Non-Votes
8,000,350
 
3,202,428
 
18,059
 
1,081,694

The 2011 Stock Incentive Plan was approved.

Item 9.01 Financial Statements and Exhibits.
 
(d) Exhibits

Exhibit
Description
10.1
ICU Medical, Inc. 2011 Stock Incentive Plan.
 
 
 
 

 

SIGNATURE

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this Report to be signed on its behalf by the undersigned hereunto duly authorized.

Date:  May 16, 2011
 
 
ICU MEDICAL, INC.
   
   
   
 
/s/ Scott E. Lamb 
 
Scott E. Lamb
 
Secretary, Treasurer and
 
Chief Financial Officer

 
 
 

 
EXHIBIT INDEX

Exhibit
Description
10.1
ICU Medical, Inc. 2011 Stock Incentive Plan.